To examine whether ATP13A2 is a possible potential target for cancer therapy, colon cancer cells were transfected with luciferase and implanted into nude mice (n = 3), and the tumors were allowed to develop for 10 days. This evidence concerns the gene ATP13A2 and colonic neoplasm.